(HealthDay)—Once-daily oral atogepant is effective for reducing the number of migraine days during a period of 12 weeks, according to a study published in the Aug. 19 issue of the New England Journal of Medicine. Jessica Ailani, M.D., from the MedStar Georgetown University Hospital in Washington, D.C., and colleagues conducted a phase 3 trial involving adults...
